"N Engl J Med"[journal] 检索结果

7861. The Cost of Applying to Medical School.

作者: Gabrielle V Campbell.;David J Skorton.
来源: N Engl J Med. 2020年382卷4期e8页

7862. Framework for "N-of-1" Experimental Therapies.

作者: Joe Brierley.;Sarah Aylett.;Dave Archard.
来源: N Engl J Med. 2020年382卷4期e7页

7863. Hereditary Thrombotic Thrombocytopenic Purpura. Reply.

作者: Johanna A Kremer Hovinga.;James N George.
来源: N Engl J Med. 2020年382卷4期394-395页

7864. Hereditary Thrombotic Thrombocytopenic Purpura.

作者: Yahsou Delmas.;Pauline Renou.;Igor Sibon.
来源: N Engl J Med. 2020年382卷4期393-394页

7865. Hereditary Thrombotic Thrombocytopenic Purpura.

作者: Aghiles Hamroun.;Camille Prouteau.;François Provôt.
来源: N Engl J Med. 2020年382卷4期392-393页

7866. Step-Up Therapy in Black Patients with Asthma. Reply.

作者: Michael E Wechsler.;Victor E Ortega.;Elliot Israel.; .
来源: N Engl J Med. 2020年382卷4期391-392页

7867. Step-Up Therapy in Black Patients with Asthma.

作者: Brian Lipworth.;Rory Chan.;Chris RuiWen Kuo.
来源: N Engl J Med. 2020年382卷4期391页

7868. Step-Up Therapy in Black Patients with Asthma.

作者: Joanna Merckx.;Jay S Kaufman.;Richard S Cooper.
来源: N Engl J Med. 2020年382卷4期390-391页

7869. Step-Up Therapy in Black Patients with Asthma.

作者: Susamita Kesh.;Bridgette L Jones.
来源: N Engl J Med. 2020年382卷4期390页

7870. Heat-Induced Brain Vitrification from the Vesuvius Eruption in c.e. 79.

作者: Pierpaolo Petrone.;Piero Pucci.;Massimo Niola.;Peter J Baxter.;Carolina Fontanarosa.;Guido Giordano.;Vincenzo Graziano.;Francesco Sirano.;Angela Amoresano.
来源: N Engl J Med. 2020年382卷4期383-384页

7871. Choosing a Mass Immunization Program against Meningococcal B.

作者: Ken Wu.;E Kim Mulholland.;Kathryn M Edwards.
来源: N Engl J Med. 2020年382卷4期379-382页

7872. Good News and Bad News - 4CMenB Vaccine for Group B Neisseria meningitidis.

作者: Lee H Harrison.;David S Stephens.
来源: N Engl J Med. 2020年382卷4期376-378页

7873. Case 3-2020: A 44-Year-Old Man with Weight Loss, Diarrhea, and Abdominal Pain.

作者: Robert C Lowe.;Jacqueline N Chu.;Theodore T Pierce.;Ana A Weil.;John A Branda.
来源: N Engl J Med. 2020年382卷4期365-374页

7874. Fluorouracil-Induced Hyperpigmentation.

作者: Jordan K Schaefer.;Nithya Ramnath.
来源: N Engl J Med. 2020年382卷4期e6页

7875. Intrahepatic Biliary Ductal Dilatation.

作者: Umberto G Rossi.;Maurizio Cariati.
来源: N Engl J Med. 2020年382卷4期364页

7876. Treating Hypertension in Chronic Obstructive Pulmonary Disease.

作者: Shannon W Finks.;Mark J Rumbak.;Timothy H Self.
来源: N Engl J Med. 2020年382卷4期353-363页

7877. Teprotumumab for the Treatment of Active Thyroid Eye Disease.

作者: Raymond S Douglas.;George J Kahaly.;Amy Patel.;Saba Sile.;Elizabeth H Z Thompson.;Renee Perdok.;James C Fleming.;Brian T Fowler.;Claudio Marcocci.;Michele Marinò.;Alessandro Antonelli.;Roger Dailey.;Gerald J Harris.;Anja Eckstein.;Jade Schiffman.;Rosa Tang.;Christine Nelson.;Mario Salvi.;Sara Wester.;Jeffrey W Sherman.;Thomas Vescio.;Robert J Holt.;Terry J Smith.
来源: N Engl J Med. 2020年382卷4期341-352页

Thyroid eye disease is a debilitating, disfiguring, and potentially blinding periocular condition for which no Food and Drug Administration-approved medical therapy is available. Strong evidence has implicated the insulin-like growth factor I receptor (IGF-IR) in the pathogenesis of this disease.

7878. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.

作者: William D Schlaff.;Ronald T Ackerman.;Ayman Al-Hendy.;David F Archer.;Kurt T Barnhart.;Linda D Bradley.;Bruce R Carr.;Eve C Feinberg.;Sandra M Hurtado.;JinHee Kim.;Ran Liu.;R Garn Mabey.;Charlotte D Owens.;Alfred Poindexter.;Elizabeth E Puscheck.;Henry Rodriguez-Ginorio.;James A Simon.;Ahmed M Soliman.;Elizabeth A Stewart.;Nelson B Watts.;Ozgul Muneyyirci-Delale.
来源: N Engl J Med. 2020年382卷4期328-340页

Uterine fibroids are hormone-responsive neoplasms that are associated with heavy menstrual bleeding. Elagolix, an oral gonadotropin-releasing hormone antagonist resulting in rapid, reversible suppression of ovarian sex hormones, may reduce fibroid-associated bleeding.

7879. Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia.

作者: Helen S Marshall.;Mark McMillan.;Ann P Koehler.;Andrew Lawrence.;Thomas R Sullivan.;Jenny M MacLennan.;Martin C J Maiden.;Shamez N Ladhani.;Mary E Ramsay.;Caroline Trotter.;Ray Borrow.;Adam Finn.;Charlene M Kahler.;Jane Whelan.;Kumaran Vadivelu.;Peter Richmond.
来源: N Engl J Med. 2020年382卷4期318-327页

The meningococcal group B vaccine 4CMenB is a new, recombinant protein-based vaccine that is licensed to protect against invasive group B meningococcal disease. However, its role in preventing transmission and, therefore, inducing population (herd) protection is uncertain.

7880. Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England.

作者: Shamez N Ladhani.;Nick Andrews.;Sydel R Parikh.;Helen Campbell.;Joanne White.;Michael Edelstein.;Xilian Bai.;Jay Lucidarme.;Ray Borrow.;Mary E Ramsay.
来源: N Engl J Med. 2020年382卷4期309-317页

In September 2015, the United Kingdom introduced the multicomponent meningococcal group B vaccine (4CMenB, Bexsero) into its publicly funded national immunization program at a reduced two-dose priming schedule for infants, with a 12-month booster.

结果排序

文献格式

出版时间

出版类型

出版语言